PL03.06 EA5181: Phase 3 Trial of Concurrent and Consolidative Durvalumab vs Consolidation Durva Alone for Unresectable Stage 3 NSCLC

Authors:
  • JVJ.M. Varlotto
    J.M. Varlotto
  • YXY. Xie
    Y. Xie
  • NPN. Pennell
    N. Pennell
  • KOK. Oettel
    K. Oettel
  • CLC.M. Lovly
    C.M. Lovly
  • VAV. Anagnostou
    V. Anagnostou
  • GSG. Srkalovic
    G. Srkalovic
  • NMN.J. Mackler
    N.J. Mackler
  • BFB.A. Faller
    B.A. Faller
  • PDP.T. Dyk
    P.T. Dyk
  • ACA.A. Chowdhary
    A.A. Chowdhary
  • GVG.M.M. Videtic
    G.M.M. Videtic

Abstract
No abstract available